CDON | Cell adhesion associated, oncogene regulated | Disease related genes Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/17377/40505_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
CMTM4 | CKLF-like MARVEL transmembrane domain containing 4 | Predicted membrane proteins
| | ![](/images/14704/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/14704/33784_A_5_4_rna_selected_60x60.jpg) | Tissue enhanced |
DCDC2 | Doublecortin domain containing 2 | Disease related genes Plasma proteins Predicted intracellular proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/31583/70634_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
GPR61 | G protein-coupled receptor 61 | G-protein coupled receptors Predicted membrane proteins
| | ![](/images/26088/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/26088/58703_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
ITGB3 | Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | Cancer-related genes CD markers Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/27852/64672_B_8_6_rna_selected_60x60.jpg) | Tissue enhanced |
KCNAB1 | Potassium voltage-gated channel, shaker-related subfamily, beta member 1 | Predicted intracellular proteins Transporters
| | ![](/images/44550/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44550/96803_B_6_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCNQ1 | Potassium voltage-gated channel, KQT-like subfamily, member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48553/123855_A_1_2_rna_selected_60x60.jpg) | Tissue enhanced |
KCTD8 | Potassium channel tetramerization domain containing 8 | Predicted intracellular proteins Predicted membrane proteins
| | ![](/images/31562/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31562/64061_B_9_8_rna_selected_60x60.jpg) | Tissue enhanced |
KHDRBS2 | KH domain containing, RNA binding, signal transduction associated 2 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/500/873_A_3_7_rna_selected_60x60.jpg) | Tissue enhanced |
KLHL14 | Kelch-like family member 14 | Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/24777/55329_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
KRT7 | Keratin 7 | Plasma proteins Predicted intracellular proteins
| | ![](/images/7272/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/28/276_A_7_6_rna_selected_60x60.jpg) | Tissue enhanced |
LPCAT2 | Lysophosphatidylcholine acyltransferase 2 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | ![](/images/7891/22296_A_3_8_rna_selected_60x60.jpg) | Tissue enhanced |
NPM2 | Nucleophosmin/nucleoplasmin 2 | Predicted intracellular proteins
| | ![](/images/41070/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/41070/86944_B_8_5_rna_selected_60x60.jpg) | Tissue enhanced |
NPNT | Nephronectin | Predicted intracellular proteins Predicted secreted proteins
| | ![](/images/50203/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/3711/10662_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |
NTRK2 | Neurotrophic tyrosine kinase, receptor, type 2 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | ![](/images/7637/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/10346/33773_A_5_4_rna_selected_60x60.jpg) | Tissue enhanced |
OCLN | Occludin | Disease related genes Potential drug targets Predicted membrane proteins Predicted secreted proteins Transporters
| | | | ![](/images/13075/32195_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PDE1A | Phosphodiesterase 1A, calmodulin-dependent | Enzymes Predicted intracellular proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/22151/49049_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
PRTG | Protogenin | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/32138/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/32138/72762_B_9_5_rna_selected_60x60.jpg) | Tissue enhanced |
SALL4 | Spalt-like transcription factor 4 | Disease related genes Predicted intracellular proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/15291/35650_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
SSC4D | Scavenger receptor cysteine rich family, 4 domains | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62611/143073_B_8_8_rna_selected_60x60.jpg) | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/35464/126315_B_8_2_rna_selected_60x60.jpg) | Tissue enhanced |